Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Menopause. 2022 Aug 20;29(10):1145–1149. doi: 10.1097/GME.0000000000002039

Table 2.

Associations of VMS to adiponectin and HMW adiponectin

Adiponectin HMW Adiponectin
Model 1 Model 2 Model 1 Model 2
B(SE) B(SE) B(SE) B(SE)
Physiologic VMS −.081 (.028)a −.083 (.029)a −.048 (.018)a −.049 (.019)a
Self-report VMS −.207 (.066)a −.206 (.067)a −.119 (.043)a −.0119 (.043)a

Model 1: age, race, education; waist circumference, HOMA (log), Model 2: Model 1 + estradiol (log)

a

p<.01

HMW, high molecular weight; HOMA, homeostatic model assessment; VMS, vasomotor symptoms

Note: Coefficients represent the differences in ug/mL adiponectin associated with each additional VMS/24 hours.